» Articles » PMID: 15100561

The Developmental, Dimensional and Diagnostic Interview (3di): a Novel Computerized Assessment for Autism Spectrum Disorders

Overview
Publisher Elsevier
Specialties Pediatrics
Psychiatry
Date 2004 Apr 22
PMID 15100561
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Autism is a diagnostic spectrum of variable severity, with significant comorbidity. No existing standardized interview measures autistic features dimensionally. The authors aimed to develop a parental autism interview that could be administered to unselected clinical and general population samples that measures both symptom intensity and comorbidity across the full range of the autistic spectrum.

Method: A computerized procedure was devised for administration by trained interviewers that generates symptom and diagnostic profiles for both autism and non-autistic conditions. Test-retest reliability and interrater reliability were assessed in unselected clinical (n = 50) and nonclinical (n = 30) populations. Concurrent validity (n = 120), discriminant validity (n = 120), and criterion validity (n = 29) were evaluated in autistic spectrum and non-autistic patients.

Results: Test-retest and interrater reliabilities were excellent (most intraclass correlation coefficients > 0.9). Concurrent validity (agreement with independent clinician formulation) was very good (mean kappa = 0.74). Criterion validity, a comparison with the Autism Diagnostic Interview, was excellent. Discrimination between autistic spectrum versus non-autistic subjects was almost perfect (sensitivity 1.0; specificity > 0.97).

Conclusions: The Developmental, Dimensional and Diagnostic Interview (3di) provides an efficient and accurate means of assessing, in dimensional terms, the presence of autistic symptoms in both clinical and normal populations. It offers novel opportunities for those engaged in research and clinical practice.

Citing Articles

Novel Procedures for Evaluating Autism Online in a Culturally Diverse Population of Children: Protocol for a Mixed Methods Pathway Development Study.

Mirzaei V, Wolstencroft J, Lockwood Estrin G, Buckley E, Sayani S, Katakis P JMIR Res Protoc. 2025; 14:e55741.

PMID: 39932780 PMC: 11862771. DOI: 10.2196/55741.


Spectral Analysis of Light-Adapted Electroretinograms in Neurodevelopmental Disorders: Classification with Machine Learning.

Constable P, Pinzon-Arenas J, Mercado Diaz L, Lee I, Marmolejo-Ramos F, Loh L Bioengineering (Basel). 2025; 12(1).

PMID: 39851292 PMC: 11761560. DOI: 10.3390/bioengineering12010015.


Where do neurodevelopmental conditions fit in transdiagnostic psychiatric frameworks? Incorporating a new neurodevelopmental spectrum.

Michelini G, Carlisi C, Eaton N, Elison J, Haltigan J, Kotov R World Psychiatry. 2024; 23(3):333-357.

PMID: 39279404 PMC: 11403200. DOI: 10.1002/wps.21225.


Identification and support of autistic individuals within the UK Criminal Justice System: a practical approach based upon professional consensus with input from lived experience.

Woodhouse E, Hollingdale J, Davies L, Al-Attar Z, Young S, Vinter L BMC Med. 2024; 22(1):157.

PMID: 38609939 PMC: 11015650. DOI: 10.1186/s12916-024-03320-3.


Utility of the 3Di short version in the identification and diagnosis of autism in children at the Kenyan coast.

Kipkemoi P, Kariuki S, Gona J, Mwangi F, Kombe M, Kipkoech C Front Psychiatry. 2024; 15:1234929.

PMID: 38487576 PMC: 10937349. DOI: 10.3389/fpsyt.2024.1234929.